The role of intravenous iron in anemia management and transfusion avoidance. (atsiveria naujas langas)

Auerbach M, Goodnough LT, Picard D, Maniatis A.

Šaltinis‎: Transfusion 2008;48(5):988-1000.

Kodas‎: PubMed 18346021

DOI‎: 10.1111/j.1537-2995.2007.01633.x

https://www.ncbi.nlm.nih.gov/pubmed/18346021 (atsiveria naujas langas)

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. (atsiveria naujas langas)

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Šaltinis‎: BJU Int 2011;108(10):1582-7.

Kodas‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653 (atsiveria naujas langas)

The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality. (atsiveria naujas langas)

Lepor H, Lipkin M, Slova D.

Šaltinis‎: Urology 2010;75(6):1424-8.

Kodas‎: PubMed 20513505

DOI‎: 10.1016/j.urology.2009.06.095

https://www.ncbi.nlm.nih.gov/pubmed/20513505 (atsiveria naujas langas)

Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. (atsiveria naujas langas)

Nieder AM, Rosenblum N, Lepor H.

Šaltinis‎: Urology 2001;57(4):737-41.

Kodas‎: PubMed 11306393

https://www.ncbi.nlm.nih.gov/pubmed/11306393 (atsiveria naujas langas)